| Product NDC: | 14789-300 |
| Proprietary Name: | Benztropine Mesylate |
| Non Proprietary Name: | BENZTROPINE MESYLATE |
| Active Ingredient(s): | 1 mg/mL & nbsp; BENZTROPINE MESYLATE |
| Administration Route(s): | PARENTERAL |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 14789-300 |
| Labeler Name: | Nexus Pharmaceuticals Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090233 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090729 |
| Package NDC: | 14789-300-02 |
| Package Description: | 5 VIAL in 1 PACKAGE (14789-300-02) > 2 mL in 1 VIAL |
| NDC Code | 14789-300-02 |
| Proprietary Name | Benztropine Mesylate |
| Package Description | 5 VIAL in 1 PACKAGE (14789-300-02) > 2 mL in 1 VIAL |
| Product NDC | 14789-300 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BENZTROPINE MESYLATE |
| Dosage Form Name | INJECTION |
| Route Name | PARENTERAL |
| Start Marketing Date | 20090729 |
| Marketing Category Name | ANDA |
| Labeler Name | Nexus Pharmaceuticals Inc |
| Substance Name | BENZTROPINE MESYLATE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anticholinergic [EPC],Antihistamine [EPC],Cholinergic Antagonists [MoA],Histamine Receptor Antagonists [MoA] |